carbodiimides has been researched along with gemcitabine in 1 studies
Studies (carbodiimides) | Trials (carbodiimides) | Recent Studies (post-2010) (carbodiimides) | Studies (gemcitabine) | Trials (gemcitabine) | Recent Studies (post-2010) (gemcitabine) |
---|---|---|---|---|---|
1,534 | 1 | 361 | 12,523 | 3,208 | 6,923 |
Protein | Taxonomy | carbodiimides (IC50) | gemcitabine (IC50) |
---|---|---|---|
Chain A, DEOXYNUCLEOSIDE KINASE | Drosophila melanogaster (fruit fly) | 0.76 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 0.19 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coyne, CP; Narayanan, L | 1 |
1 other study(ies) available for carbodiimides and gemcitabine
Article | Year |
---|---|
Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549).
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Carbodiimides; Cell Line, Tumor; Chemistry Techniques, Synthetic; Deoxycytidine; Drug Design; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Gemcitabine; Humans; Immunoglobulin G; Immunoglobulins; Lung Neoplasms; Polymerization; Receptor, IGF Type 1 | 2017 |